IL22 and colitis: Tregs prevent ILC3-associated colitis by inhibiting IL-23 and IL-1β production from intestinal-resident C-X3-C Motif Chemokine Receptor 1 (CX3CR1)+ macrophages, which restrains ILC3-linked IL-22 production [141] (Figure 6).